Dicerna Pharmaceuticals Inc

CIK 1399529 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Dicerna Pharmaceuticals Inc.

Recent SEC filings

FiledFormAccession number
Feb 14, 2022SC 13G/A0001193125-22-039084
Jan 10, 202215-12B0000950103-22-000388
Dec 30, 2021EFFECT9999999995-22-000009
Dec 30, 2021EFFECT9999999995-22-000005
Dec 30, 2021EFFECT9999999995-22-000002
Dec 30, 2021EFFECT9999999995-22-000007
Dec 29, 202140001399529-21-000199
Dec 29, 202140000899243-21-050036
Dec 29, 202140001399529-21-000205
Dec 29, 202140001399529-21-000206
Dec 29, 202140001399529-21-000195
Dec 29, 202140001399529-21-000204
Dec 29, 202140001399529-21-000197
Dec 29, 202140001399529-21-000198
Dec 29, 202140001399529-21-000203
Dec 29, 202140001399529-21-000202
Dec 29, 202140001399529-21-000194
Dec 29, 202140001399529-21-000193
Dec 29, 202140001399529-21-000201
Dec 29, 202140001399529-21-000200
Dec 29, 202140001399529-21-000196
Dec 28, 2021POSASR0001193125-21-367559
Dec 28, 2021S-8 POS0001193125-21-367534
Dec 28, 202125-NSE0001354457-21-001513
Dec 28, 2021SC TO-T/A0000950103-21-020298